These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31310679)

  • 21. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
    Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA
    Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic mismatch repair testing in evaluation of Lynch syndrome: The gap between preferred and current practices.
    Williams D; Vilar E; Shakrukh Hashmi S; Choates M; Noblin S; Mork M
    J Genet Couns; 2020 Oct; 29(5):728-736. PubMed ID: 31896172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis.
    Ryan NAJ; Glaire MA; Blake D; Cabrera-Dandy M; Evans DG; Crosbie EJ
    Genet Med; 2019 Oct; 21(10):2167-2180. PubMed ID: 31086306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS).
    Zeimet AG; Mori H; Petru E; Polterauer S; Reinthaller A; Schauer C; Scholl-Firon T; Singer C; Wimmer K; Zschocke J; Marth C
    Arch Gynecol Obstet; 2017 Jul; 296(1):123-127. PubMed ID: 28510097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of two Lynch screening strategies in endometrial cancer in a California health system.
    Lentz SE; Salyer CV; Dontsi M; Armstrong MA; Hoodfar E; Alvarado MM; Avila M; Nguyen NT; Powell CB
    Gynecol Oncol; 2020 Jul; 158(1):158-166. PubMed ID: 32386910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
    Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE
    Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer.
    Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ
    Front Immunol; 2019; 10():3023. PubMed ID: 31998307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions?
    Lucas E; Chen H; Molberg K; Castrillon DH; Rivera Colon G; Li L; Hinson S; Thibodeaux J; Lea J; Miller DS; Zheng W
    Int J Gynecol Pathol; 2019 Nov; 38(6):533-542. PubMed ID: 30383610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers.
    Mascarenhas L; Shanley S; Mitchell G; Spurdle AB; Macrae F; Pachter N; Buchanan DD; Ward RL; Fox S; Duxbury E; Driessen R; Boussioutas A
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):417-425. PubMed ID: 30294856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerations.
    Levine MD; Barrington DA; Hampel H; Goodfellow PJ; Cohn DE
    Gynecol Oncol; 2022 Sep; 166(3):538-542. PubMed ID: 35871048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.
    Hodan R; Rodgers-Fouche L; Arora S; Dominguez-Valentin M; Kanth P; Katona BW; Mraz KA; Roberts ME; Vilar E; Soto-Azghani CM; Brand RE; Esplin ED; Perez K
    J Genet Couns; 2022 Aug; 31(4):949-955. PubMed ID: 35218578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.
    Li D; Hoodfar E; Jiang SF; Udaltsova N; Pham NP; Jodesty Y; Armstrong MA; Hung YY; Baker RJ; Postlethwaite D; Ladabaum U; Levin TR; Corley DA; Bergoffen J
    Ann Intern Med; 2019 Jul; 171(1):19-26. PubMed ID: 31181578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
    Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
    Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families.
    Long Q; Peng Y; Tang Z; Wu C
    Int J Clin Exp Pathol; 2014; 7(10):7297-303. PubMed ID: 25400828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current clinical topics of Lynch syndrome.
    Tanakaya K
    Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome.
    Musulén E; Sanz C; Muñoz-Mármol AM; Ariza A
    Hum Pathol; 2014 Jul; 45(7):1388-96. PubMed ID: 24768606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gynecological surveillance of women with Lynch syndrome in Sweden.
    Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
    Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lynch Syndrome Screening of Women with Endometrial Cancer: Feasibility and Outcomes in a Community Program.
    Turashvili G; Colgan T; McLachlin M; Lin H; Gharbharan R
    J Obstet Gynaecol Can; 2022 Feb; 44(2):142-147. PubMed ID: 34656766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
    J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying Lynch Syndrome in Women Presenting With Endometrial Carcinoma Under the Age of 50 Years.
    Anagnostopoulos A; McKay VH; Cooper I; Campbell F; Greenhalgh L; Kirwan J
    Int J Gynecol Cancer; 2017 Jun; 27(5):931-937. PubMed ID: 28498244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.